Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
出版年份 2022 全文链接
标题
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
作者
关键词
-
出版物
NATURE MEDICINE
Volume 28, Issue 2, Pages 383-391
出版商
Springer Science and Business Media LLC
发表日期
2022-02-04
DOI
10.1038/s41591-021-01660-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates
- (2021) Nicole Darricarrère et al. Science Translational Medicine
- Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
- (2021) Maya Sangesland et al. Vaccines
- Next-generation influenza vaccines: opportunities and challenges
- (2020) Chih-Jen Wei et al. NATURE REVIEWS DRUG DISCOVERY
- Next-Generation Influenza Vaccines
- (2020) Masaru Kanekiyo et al. Cold Spring Harbor Perspectives in Medicine
- Novel correlates of protection against pandemic H1N1 influenza A virus infection
- (2019) Sophia Ng et al. NATURE MEDICINE
- The 1918 influenza pandemic: 100 years of questions answered and unanswered
- (2019) Jeffery K. Taubenberger et al. Science Translational Medicine
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
- (2019) David I Bernstein et al. LANCET INFECTIOUS DISEASES
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
- (2018) A Danielle Iuliano et al. LANCET
- Structural insights into the design of novel anti-influenza therapies
- (2018) Nicholas C. Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural insights into the design of novel anti-influenza therapies
- (2018) Nicholas C. Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
- (2017) Edward A. Belongia et al. Expert Review of Vaccines
- Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
- (2017) Sarah F. Andrews et al. Cold Spring Harbor Perspectives in Biology
- Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
- (2017) Florian Krammer et al. Cold Spring Harbor Perspectives in Biology
- Antibody-dependent cellular cytotoxicity and influenza virus
- (2017) Hillary A Vanderven et al. Current Opinion in Virology
- Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
- (2017) Daniel Stadlbauer et al. mSphere
- An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
- (2017) Adam D. DeZure et al. npj Vaccines
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
- (2016) M. Gordon Joyce et al. CELL
- Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza
- (2016) Veronika I. Zarnitsyna et al. PLoS Pathogens
- A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
- (2016) Raffael Nachbagauer et al. npj Vaccines
- Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets
- (2015) Raffael Nachbagauer et al. JOURNAL OF VIROLOGY
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
- (2015) Irina Isakova-Sivak et al. Human Vaccines & Immunotherapeutics
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
- (2014) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
- (2013) Julie E. Ledgerwood, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, LeeJah Chang, Mary E. Enama, Cynthia S. Hendel, Sandra Sitar, Robert T. Bailer, Richard A. Koup, John R. Mascola, Gary J. Nabel, Barney S. Graham et al. JOURNAL OF INFECTIOUS DISEASES
- Risk Assessment of H2N2 Influenza Viruses from the Avian Reservoir
- (2013) J. C. Jones et al. JOURNAL OF VIROLOGY
- H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
- (2012) Kawsar R. Talaat et al. Influenza and Other Respiratory Viruses
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- Vaccinate for the next H2N2 pandemic now
- (2011) Gary J. Nabel et al. NATURE
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
- (2010) Gary J Nabel et al. NATURE MEDICINE
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search